Quakertown, PA, United States of America

Robert Breese


 

 

Average Co-Inventor Count = 13.0

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2010-2014

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Robert Breese

Introduction

Robert Breese is an accomplished inventor based in Quakertown, PA (US). He holds a total of 5 patents that contribute significantly to the field of biomedical research, particularly in the study of Alzheimer's Disease.

Latest Patents

One of his latest patents is titled "Anti-ADDL antibodies and uses thereof." This invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, commonly known as ADDLs. The antibodies developed by Breese can distinguish between Alzheimer's Disease and control human brain extracts. They are useful in methods for detecting ADDLs and diagnosing Alzheimer's Disease. Furthermore, these antibodies block the binding of ADDLs to neurons, the assembly of ADDLs, and tau phosphorylation. As a result, they are valuable in methods for preventing and treating diseases associated with soluble oligomers of amyloid β 1-42.

Career Highlights

Throughout his career, Robert Breese has made significant contributions to the field of research. He has worked with notable institutions such as Northwestern University and Merck Sharp & Dohme Corporation, where he has furthered his research and development efforts.

Collaborations

Breese has collaborated with esteemed colleagues, including Paul Acton and Zhiqiang An, to advance his research initiatives and innovations.

Conclusion

Robert Breese's work in developing antibodies for Alzheimer's Disease showcases his dedication to innovation in biomedical research. His contributions are vital in the ongoing fight against this debilitating condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…